CoChat

Non-fibrillar oligomeric species of the amyloid ABri peptide, implicated in familial British dementia, are more potent at inducing apoptotic cell death than protofibrils or mature fibrils11Edited by J. Karn

El-Agnaf, Omar M.A, Nagala, Sidhartha, Patel, Bhroma P, Austen, Brian M · 2001 · Journal of Molecular Biology
Cited by 59

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1006/jmbi.2001.4743

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 34

  1. Worster-Drought, 1933, Familial cerebral amyloid angiopathy with nonneuritic plaque formation, J. Neurol. Psychopathol., 14, 27, 10.1136/jnnp.s1-14.53.27 · DOI
  2. Aikawa, 1985, Atypical Alzheimer’s disease with spastic paresis and ataxia, Ann. Neurol., 17, 297, 10.1002/ana.410170313 · DOI · Paper page
  3. Plant, 1990, Familial cerebral amyloid angiopathy with nonneuritic amyloid plaque formation, Brain, 113, 721, 10.1093/brain/113.3.721 · DOI · Paper page
  4. Lansbury, 1999, Evolution of amyloid, Proc. Natl Acad. Sci. USA, 96, 3342, 10.1073/pnas.96.7.3342 · DOI · Paper page
  5. Perutz, 1999, Glutamine repeats and neurodegenerative diseases, Trends Biochem. Sci., 24, 58, 10.1016/S0968-0004(98)01350-4 · DOI · Paper page
  6. El-Agnaf, 2000, Review, J. Struct. Biol., 130, 300, 10.1006/jsbi.2000.4262 · DOI
  7. Forloni, 1993, Neurotoxicity of a prion protein fragment, Nature, 362, 543, 10.1038/362543a0 · DOI · Paper page
  8. El-Agnaf, 1998, Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments, FEBS Letters, 440, 71, 10.1016/S0014-5793(98)01418-5 · DOI · Paper page
  9. Roher, 1996, Morphology and toxicity of Abeta-(1–42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer’s disease, J. Biol. Chem., 271, 20631, 10.1074/jbc.271.34.20631 · DOI · Paper page
  10. Seilheimer, 1997, The toxicity of the Alzheimer’s beta-amyloid peptide correlates with a distinct fiber morphology, J. Struct. Biol., 119, 59, 10.1006/jsbi.1997.3859 · DOI · Paper page
  11. Walsh, 1997, Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate, J. Biol. Chem., 272, 22364, 10.1074/jbc.272.35.22364 · DOI · Paper page
  12. El-Agnaf, 2000, Oligomerization and toxicity of beta-amyloid-42 implicated in Alzheimer’s disease, Biochem. Biophys. Res. Commun., 273, 1003, 10.1006/bbrc.2000.3051 · DOI · Paper page
  13. Lambert, 1998, Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins, Proc. Natl Acad. Sci. USA, 95, 6448, 10.1073/pnas.95.11.6448 · DOI · Paper page
  14. Hartley, 1999, Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons, J. Neurosci., 19, 8876, 10.1523/JNEUROSCI.19-20-08876.1999 · DOI · Paper page
  15. Howlett, 1999, Biological activity associated with a high molecular weight form of β-amyloid, Alzheimer’s Rep., 2, 71
  16. Bhatia, 2000, Fresh and globular amyloid beta protein (1–42) induces rapid cellular degeneration, FASEB J., 14, 1233, 10.1096/fasebj.14.9.1233 · DOI · Paper page
  17. Ward, 2000, Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of beta-amyloid peptide, Biochem. J., 15, 137, 10.1042/bj3480137 · doi:10.1042/bj3480137 · Paper page
  18. Zhu, 2000, Fresh and nonfibrillar amyloid beta protein(1–40) induces rapid cellular degeneration in aged human fibroblasts, FASEB J., 14, 1244, 10.1096/fasebj.14.9.1244 · DOI · Paper page
  19. Sian, 2000, Oligomerization of beta-amyloid of the Alzheimer’s and the Dutch-cerebral-haemorrhage types, Biochem. J., 349, 299, 10.1042/bj3490299 · doi:10.1042/bj3490299
  20. Conway, 2000, Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson’s disease, Proc. Natl Acad. Sci. USA, 97, 571, 10.1073/pnas.97.2.571 · DOI · Paper page
  21. Chiesa, 1998, Neurological illness in transgenic mice expressing a prion protein with an insertional mutation, Neuron, 21, 1339, 10.1016/S0896-6273(00)80653-4 · DOI · Paper page
  22. Saudou, 1998, Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions, Cell, 95, 55, 10.1016/S0092-8674(00)81782-1 · DOI · Paper page
  23. Masliah, 2000, Dopaminergic loss and inclusion body formation in alpha-synuclein mice, Science, 287, 1265, 10.1126/science.287.5456.1265 · DOI · Paper page
  24. El-Agnaf, 2001, Effect of the disulophide bridge and the C-terminal extension on the oligomerisation of the amyloid peptide ABri implicated in familial British dementia, Biochemistry, 40, 3449, 10.1021/bi002287i · DOI · Paper page
  25. Cooper, 1974, Selective amyloid staining as a function of amyloid composition and structure. Histochemical analysis of the alkaline Congo red, standardized toluidine blue, and iodine methods, Lab. Invest., 31, 232
  26. Elghetany, 1988, Methods for staining amyloid in tissues, Stain. Technol., 63, 201, 10.3109/10520298809107185 · DOI · Paper page
  27. Elghetany, 1989, The congo red stain revisited, Ann. Clin. Lab. Sci., 19, 190
  28. Shearman, 1995, The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides, J. Neurochem., 65, 218, 10.1046/j.1471-4159.1995.65010218.x · DOI · Paper page
  29. Liu, 1997, Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis, J. Neurochem., 69, 2285, 10.1046/j.1471-4159.1997.69062285.x · DOI · Paper page
  30. Shearman, 1994, Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death, Proc. Natl Acad. Sci. USA, 91, 1470, 10.1073/pnas.91.4.1470 · DOI · Paper page
  31. Huang, 2000, Alternate aggregation pathways of the Alzheimer beta-amyloid peptide, J. Biol. Chem., 275, 36436, 10.1074/jbc.M005698200 · DOI
  32. Mead, 2000, Familial British dementia with amyloid angiopathy, Brain, 123, 975, 10.1093/brain/123.5.975 · DOI · Paper page
  33. Goldberg, 2000, Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson’s disease?, Nature Cell Biol., 2, E115, 10.1038/35041081 · DOI · Paper page
  34. El-Agnaf, 1998, The N-terminal region of non-A beta component of Alzheimer’s disease amyloid is responsible for its tendency to assume beta-sheet and aggregate to form fibrils, Eur. J. Biochem., 258, 157, 10.1046/j.1432-1327.1998.2580157.x · DOI

Cited by

See all 59

Metadata

Authors
El-Agnaf, O. M. A., Nagala, S., Patel, B. P., & Austen, B. M.
Venue
Journal of Molecular Biology
Publisher
Elsevier BV
Published
2001-06
Volume
310
Issue
1
Pages
157-168
ISSN
0022-2836
Cited by
59
References
11
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Non-fibrillar oligomeric species of the amyloid ABri peptide, implicated in familial British dementia, are more potent at inducing apoptotic cell death than protofibrils or mature fibrils11Edited by J. Karn. https://app.cochat.ai/papers/10.1006/jmbi.2001.4743
The paper
El-Agnaf, O. M. A., Nagala, S., Patel, B. P., & Austen, B. M. (2001). Non-fibrillar oligomeric species of the amyloid ABri peptide, implicated in familial British dementia, are more potent at inducing apoptotic cell death than protofibrils or mature fibrils11Edited by J. Karn. Journal of Molecular Biology. https://doi.org/10.1006/jmbi.2001.4743

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.